Corpus Intelligence IC Memo — ANMED HEALTH REHABILITATION HOSPITAL 2026-04-26 09:35 UTC
IC Memo — ANMED HEALTH REHABILITATION HOSPITAL
Investment Committee Memorandum | SC | 60 beds | Grade C | EBITDA uplift $2.0M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ANMED HEALTH REHABILITATION HOSPITAL

CCN 423029 | ANDERSON, SC | 60 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ANMED HEALTH REHABILITATION HOSPITAL is a 60-bed community hospital in ANDERSON, SC with $27.0M in net patient revenue and a 35.5% operating margin. The hospital serves a payer mix of 82.4% Medicare, 0.0% Medicaid, and 17.6% commercial.

Thesis: Turnaround. Our ML models identify $2.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 35.5% to 42.9% (+736bps).

Net Revenue HCRIS$27.0M
Current EBITDA COMPUTED$9.6M
Operating Margin COMPUTED35.5%
Occupancy HCRIS74.0%
Revenue / Bed COMPUTED$449K
Net-to-Gross HCRIS74.6%
Distress Probability MLnan%

2. Market Context & Competitive Position

85
SC Hospitals
1.3%
State Median Margin
45
Comparable Hospitals

SC has 85 Medicare-certified hospitals with a median operating margin of 1.3%. The target's margin of 35.5% places it above the state median. Among 45 size-comparable peers (30-120 beds), the median margin is 2.0%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (30-120), prioritizing same-state peers. 45 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ANMED HEALTH REHABILITATION HO (Target)SC60$27.0M35.5%
PH PATEWOOD HOSPITALSC64$229.8M38.0%
EAST COOPER REGIONAL MEDICAL CSC120$206.1M28.3%
GEORGETOWN MEMORIAL HOSPITALSC68$168.0M-4.6%
HILTON HEAD HOSPITALSC109$165.7M29.2%
PH GREER MEMORIAL HOSPITALSC66$161.3M31.3%
PH BAPTIST PARKRIDGE HOSPITALSC78$159.8M18.1%
PELHAM MEDICAL CENTERSC48$137.2M17.1%
MUSC HEALTH LANCASTER MEDICAL SC78$128.2M-10.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.0M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$566K+210bp18mo
Cost to Collect4.5%2.5%$539K+200bp12mo
Denial Rate Reduction12.0%6.5%$534K+198bp12mo
A/R Days Reduction5200.0%3800.0%$328K+122bp9mo
Clean Claim Rate88.0%96.0%$17K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$566K
Cost to Collect
$539K
Denial Rate Reduction
$534K
A/R Days Reduction
$328K
Clean Claim Rate
$17K
Total EBITDA Uplift$2.0M
Current EBITDA$9.6M
+ RCM Uplift+$2.0M
Pro Forma EBITDA$11.6M
Current Margin35.5%
Pro Forma Margin42.9%
WC Released (1x)$1.0M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$14.7M$83.0M5.63x41.3%
Base (11x exit)10.0x11.0x$14.7M$96.1M6.52x45.5%
Bull Case9.0x11.0x$13.3M$107.5M8.10x52.0%
Bull (12x exit)9.0x12.0x$13.3M$121.2M9.13x55.6%
Bear Case11.0x10.0x$16.2M$68.3M4.21x33.3%
Bear (11x exit)11.0x11.0x$16.2M$80.4M4.96x37.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 82.4% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 45 hospitals with 30-120 beds
  • Same-state prioritization (n=46)
  • Comp margins: P25=-7.2% / P50=2.0% / P75=17.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.